MedTrace Logo

Confocal Analysis of Corneal Structures of Symptomatic Allergic Conjunctivitis Patients

NCT01697969 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2014-08-18

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to descriptively evaluate the corneal structures of allergic conjunctivitis patients.

Conditions

  • Allergic Conjunctivitis

Interventions

DRUG

Olopatadine hydrochloride ophthalmic solution, 0.2%

Sponsors & Collaborators

  • Alcon Research

    lead INDUSTRY

Principal Investigators

  • Christine Sindt, OD, FAAO · University of Iowa

  • Pam Kaur, MS PhD · Alcon Research

Study Design

Allocation
NA
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2013-07-31
Completion
2013-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01697969 on ClinicalTrials.gov